You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,

    Completed
    • Age-Related Macular Degeneration
    • +2 more
    • Early disclosure
    • Late disclosure
    • Salt Lake City, Utah
      University of Utah John A. Moran Eye Center
    Aug 10, 2022

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • BD311
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Aug 22, 2022

    Optical Coherence Tomography Angiography Criteria Of The

    Not yet recruiting
    • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
    • Optical coherence tomography angiography
    • (no location specified)
    Sep 27, 2022

    Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

    Not yet recruiting
    • Age Related Macular Degeneration (AMD)
    • SPIN
    • Non-aerobic, stretching/balance intervention Control
    • Decatur, Georgia
      Atlanta VA Medical and Rehab Center, Decatur, GA
    Jun 26, 2023

    Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

    Recruiting
    • Polypoidal Choroidal Vasculopathy
    • +2 more
    • Intravitreal aflibercept injection
    • Seoul, Korea, Republic of
      Jae Hui Kim
    Dec 20, 2022

    Deep Learning OCT and OCTA in NVC

    Recruiting
    • Macular Degeneration Choroidal Neovascularization
    • Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
    • Naples, Italy
      Federico II University
    Aug 3, 2023

    Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

    Not yet recruiting
    • Age-Related Macular Degeneration
    • +2 more
    • Non-invasive ultrasound retinal stimulation Device
    • (no location specified)
    Jun 19, 2023

    Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

    Not yet recruiting
    • Neovascular (Wet) Age-related Macular Degeneration
    • Aflibercept(BAY86-5321, Eylea)
    • (no location specified)
    Jul 22, 2022

    Geographic Atrophy Trial (BI 771716)

    Not yet recruiting
    • Geographic Atrophy
    • BI 771716
    • (no location specified)
    Aug 29, 2023

    Geographic Atrophy Insights (i-GAIN) Natural History Study

    Recruiting
    • Dry Age-related Macular Degeneration
    • +6 more
      • Belfast, United Kingdom
      • +11 more
      Mar 22, 2023

      Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)

      Recruiting
      • Macular Degeneration, Choroidal Neovascularization
      • episcleral brachytherapy
      • 'Aiea, Hawaii
      • +1 more
      Feb 11, 2022

      Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

      Not yet recruiting
      • Macular Degeneration, Age Related
      • +4 more
      • VISUPRIME
      • Placebo
      • Perugia, PG, Italy
        Ospedale Santa Maria della Misericordia
      Dec 22, 2022

      Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in Australia

      Completed
      • Age-related Macular Degeneration
      • +2 more
      • bevacizumab
      • ranibizumab
      • Hurstville, New South Wales, Australia
      • +8 more
      May 7, 2021

      Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial

      Recruiting
      • Diabetic Macular Edema
      • +4 more
      • Anti-vascular endothelial growth factors (Anti-VEGFs)
      • Banhā, Benha, Egypt
        Ahmed Abdelshafy Tabl
      Aug 8, 2022

      Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States

      Completed
      • Age-related Macular Degeneration
      • +2 more
      • bevacizumab
      • ranibizumab
      • Tucson, Arizona
      • +49 more
      Feb 15, 2022

      Development of Novel Clinical Endpoints in Intermediate AMD

      Active, not recruiting
      • Age Related Macular Degeneration (AMD)
      • No intervention
      • Copenhagen, Denmark
      • +19 more
      May 23, 2022

      Non Exudative AMD Imaged With SS-OCT

      Active, not recruiting
      • Dry Macular Degeneration
      • SS-OCT imaging
      • Los Angeles, California
      • +4 more
      Mar 8, 2022

      Non Exudative AMD Imaged With SS-OCT- Extension

      Recruiting
      • Dry Macular Degeneration
      • SS-OCT imaging
      • Los Angeles, California
      • +4 more
      Mar 8, 2022

      Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)

      Terminated
      Has Results
      • Choroidal Neovascularization
      • Wet Macular Degeneration
      • ICON-1
      • aflibercept
      • Beverly Hills, California
      • +7 more
      Mar 21, 2021

      Anti-VEGF in Real-world

      Recruiting
      • Neovascular Age-related Macular Edema
      • +5 more
      • Beijing, Beijing, China
        Wen-Bin Wei
      Feb 2, 2022

      Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)

      Completed
      • Age-related Macular Degeneration
      • Blood draw and urine collection
      • Coimbra, Portugal
        AIBILI
      Jan 6, 2023

      Neovascular Age-related Macular Degeneration Trial in Phoenix (CLS-AX, Aflibercept)

      Recruiting
      • Neovascular Age-related Macular Degeneration
      • Phoenix, Arizona
        Retinal Research Institute, LLC
      Jun 4, 2023

      AMD, nAMD, Wet Age-related Macular Degeneration Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Aflibercept (EYLEA®))

      Recruiting
      • AMD
      • +5 more
      • RGX-314 Dose 1
      • +2 more
      • Encino, California
      • +16 more
      Jun 2, 2022

      Neovascular Age-Related Macular Degeneration, Choroidal Neovascularization Trial (Brolucizumab ophthalmic solution, Aflibercept

      Completed
      Has Results
      • Neovascular Age-Related Macular Degeneration
      • Choroidal Neovascularization
      • Brolucizumab ophthalmic solution
      • Aflibercept ophthalmic solution
      • (no location specified)
      Sep 9, 2020